New generation adenoviral vectors improve gene transfer by coxsackie and adenoviral receptor-independent cell entry  Paul N. Reynolds, David T. Curiel 

Slides:



Advertisements
Similar presentations
Gene therapy and viral vector
Advertisements

Control of Gene Expression
Up-Regulation of Activating Transcription Factor-5 Suppresses SAP Expression to Activate T Cells in Hemophagocytic Syndrome Associated with Epstein-Barr.
Induction of apoptosis of lung and esophageal cancer cells treated with the combination of histone deacetylase inhibitor (trichostatin A) and protein.
Genetic Manipulation of Brown Fat Via Oral Administration of an Engineered Recombinant Adeno-associated Viral Serotype Vector  Wei Huang, Travis McMurphy,
Harald D. Rupprecht, M.D, Yoshitaka Akagi, Annette Keil, Gerhard Hofer 
Volume 9, Issue 2, Pages (February 2004)
Volume 19, Issue 1, Pages (January 2011)
Volume 2, Issue 1, Pages (July 2000)
by Hong Hao, Huiling Qi, and Manohar Ratnam
Volume 61, Issue 1, Pages S79-S84 (January 2002)
Targeting Mesothelioma Using an Infectivity Enhanced Survivin-Conditionally Replicative Adenoviruses  Zeng B. Zhu, MD, Sharmila K. Makhija, MD, Baogen.
Blocking Sp1 Transcription Factor Broadly Inhibits Extracellular Matrix Gene Expression In Vitro and In Vivo: Implications for the Treatment of Tissue.
Volume 120, Issue 1, Pages (January 2001)
Volume 6, Issue 2, Pages (February 1997)
Ligation of CD31 (PECAM-1) on Endothelial Cells Increases Adhesive Function of vβ3 Integrin and Enhances β1 Integrin-Mediated Adhesion of Eosinophils.
Ding Ai, John Y.-J. Shyy, Yi Zhu  Kidney International 
Volume 60, Issue 1, Pages (July 2001)
Induction of apoptosis of lung and esophageal cancer cells treated with the combination of histone deacetylase inhibitor (trichostatin A) and protein.
Targeted adenoviral gene transfer to the kidney
Opening a Chromatin Gate to Metastasis
Evaluation of polyethylene glycol modification of first-generation and helper-dependent adenoviral vectors to reduce innate immune responses  Hoyin Mok,
Kupffer Cells Mediate Leptin-Induced Liver Fibrosis
Sung Il Kim, Hey Jin Kim, Dong Cheol Han, Hi Bahl Lee, M.D 
Renoprotective effects of vitamin D analogs
Volume 9, Issue 2, Pages (February 2004)
Human Papilloma Virus E6 and E7 Proteins Support DNA Replication of Adenoviruses Deleted for the E1A and E1B Genes  Dirk S. Steinwaerder, Cheryl A. Carlson,
Volume 91, Issue 1, Pages 2-3 (January 2017)
Eukaryotic Transcription Activation: Right on Target
Volume 69, Issue 1, Pages (January 2006)
Volume 14, Issue 1, Pages (July 2006)
Volume 2, Issue 1, Pages (July 2000)
Development of Peptide-targeted Lipoplexes to CXCR4-expressing Rat Glioma Cells and Rat Proliferating Endothelial Cells  Wouter HP Driessen, Nobutaka.
Volume 24, Issue 9, Pages (September 2016)
Volume 2, Issue 5, Pages (November 2005)
Volume 15, Issue 9, Pages (September 2007)
Microtubule-Targeted Drugs Inhibit VEGF Receptor-2 Expression by both Transcriptional and Post-Transcriptional Mechanisms  Markus Meissner, Andreas Pinter,
Toward the development of podocyte-specific drugs
Volume 62, Issue 3, Pages (September 2002)
Volume 60, Issue 3, Pages (September 2001)
New vitamin D analogs Kidney International
Volume 21, Issue 4, Pages (April 2013)
Smad proteins and transforming growth factor-β signaling
Vitamin D activates type A natriuretic peptide receptor gene transcription in inner medullary collecting duct cells  S. Chen, K. Olsen, C. Grigsby, D.G.
Volume 62, Issue 3, Pages (September 2002)
Strong Promoters Are the Key to Highly Efficient, Noninflammatory and Noncytotoxic Adenoviral-Mediated Transgene Delivery into the Brain in Vivo  Christian.
Romain Debret, Richard R
Engineering HIV-Resistant, Anti-HIV Chimeric Antigen Receptor T Cells
In vivo gene transfer to kidney by lentiviral vector
Volume 15, Issue 2, Pages (February 2007)
Volume 61, Issue 1, Pages S94-S98 (January 2002)
Volume 5, Issue 6, Pages (June 2002)
Nerve Growth Factor Receptor-Mediated Gene Transfer
STAT proteins mediate angiotensin II–induced production of TIMP-1 in human proximal tubular epithelial cells  Xiangmei Chen, Jianzhong Wang, Feng Zhou,
Volume 64, Pages S33-S38 (October 2003)
Adenovirus-mediated gene transfer to renal glomeruli in rodents
Evaluation of Twenty-One Human Adenovirus Types and One Infectivity-Enhanced Adenovirus for the Treatment of Malignant Melanoma  Dennis Hoffmann, Wibke.
Volume 8, Issue 1, Pages (July 2003)
Volume 18, Issue 2, Pages (February 2010)
Volume 19, Issue 7, Pages (July 2011)
Markus Bitzer, Iddo Z. Ben-Dov, Thomas Thum  Kidney International 
Cellular iron metabolism
Transcription factor-κB (NF-κB) and renal disease
Volume 61, Issue 6, Pages (June 2002)
Volume 20, Issue 5, Pages (May 2012)
Volume 4, Issue 6, Pages (December 2001)
Another niche for Notch
Volume 49, Issue 2, Pages (January 2013)
Volume 16, Issue 12, Pages (December 2008)
Hildegard Büning, Arun Srivastava 
Presentation transcript:

New generation adenoviral vectors improve gene transfer by coxsackie and adenoviral receptor-independent cell entry  Paul N. Reynolds, David T. Curiel  Kidney International  Volume 61, Issue 1, Pages S24-S31 (January 2002) DOI: 10.1046/j.1523-1755.2002.0610s1024.x Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 1 The pathway of adenoviral infection. Primary binding is mediated by the interaction of the knob domain of the Ad fiber with the cellular receptor, CAR. This is followed by an interaction between RGD motifs in the penton base with cellular integrins, which mediates internalization of the virion into an endosome. Endosomal disruption occurs via mechanisms involving the penton base and the low endosomal pH. The partially disassembled virion particle is then transported to the nuclear membrane for release of viral DNA into the nucleus. Kidney International 2002 61, S24-S31DOI: (10.1046/j.1523-1755.2002.0610s1024.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 2 Redirection of adenoviral infection mediated by conjugate of FGF2 with the Fab fragment of an antiknob-neutralizing mAb achieves enhanced gene delivery. (A) Retargeting schema. (B) 3H-labeled Ad vector alone or after incubation with Fab or Fab-FGF2 was bound to human umbilical vein endothelial cells at 4°C for one hour. Following washing, cell bound radioactivity (CPM) was measured in a scintillation counter. (C) The optimal neutralizing dose of Fab or Fab-FGF2 was incubated with 108 particles of an Ad vector carrying the luciferase reporter gene (AdCMVLuc). After 30 minutes, the complexes were added in triplicate to 24-well plates containing vein endothelial cells. After incubation for 24 hours at 37°C, cells were lysed, and extracts were assayed for luciferase activity. Specificity of FGF2 retargeting was confirmed by blocking with heparin, excess FGF, or anti-FGF antiserum. Free FGF2 alone had no stimulatory effect on Ad-mediated luciferase expression. adapted from Reynolds et al [29] Kidney International 2002 61, S24-S31DOI: (10.1046/j.1523-1755.2002.0610s1024.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 3 Genetic modification of the HI loop of the fiber knob domain. The knob trimer, viewed along the three-fold symmetry axis (picture courtesy R. Gerard, adapted from Xia et al [51]). The position of the HI loops, into which the targeting RGD motif was inserted, is shown. The accessibility of this region for binding to cellular targets is seen. Kidney International 2002 61, S24-S31DOI: (10.1046/j.1523-1755.2002.0610s1024.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 4 Combined transductional and transcriptional targeting improves the specificity of transgene expression in vivo. Stepwise improvement in transgene expression in pulmonary endothelium is shown. Rats were injected via the tail vein with vectors carrying the luciferase reporter gene. Then organs were harvested, and luciferase activity was determined three days later. (A) Untargeted vector, AdCMVLuc, showing dominant transgene expression in liver and spleen. (B) Addition of Fab-9B9 for targeting to angiotensin-converting enzyme leads to enhanced pulmonary gene expression and reduction in liver expression (note log scale). (C) AdfltLuc, containing an endothelial specific promoter results in dramatic reduction in expression in all organs. (D) AdfltLuc + Fab-9B9 restores transgene expression levels in lungs but still further reduces expression in nontarget liver and spleen, thereby dramatically improving selectivity ratio. adapted from Reynolds et al [68] Kidney International 2002 61, S24-S31DOI: (10.1046/j.1523-1755.2002.0610s1024.x) Copyright © 2002 International Society of Nephrology Terms and Conditions